Iversen, Lars Kurvits, Merle Snel-Prentø, Anja Marieke Menter, Alan Calcipotriol/Betamethasone Dipropionate Cutaneous Foam Treatment for Psoriasis in Patients With Bsa 5–15% and PGA ≥3: Post-Hoc Analysis From Three Randomized Controlled Trials <p>The above summary slide represents the opinions of the authors. For a full list of declarations, including funding and author disclosure statements, please see the full text online (see “read the peer-reviewed publication” opposite).<br></p> <p>© The authors, CC-BY-NC 2020.<b> </b></p> Betamethasone dipropionate;BSA ≥5%;Calcipotriol;Enstilar;Foam;Moderate-to-severe;PGA ≥3;Post-hoc;Psoriasis;Topical application 2020-07-29
    https://adisjournals.figshare.com/articles/media/Calcipotriol_Betamethasone_Dipropionate_Cutaneous_Foam_Treatment_for_Psoriasis_in_Patients_With_Bsa_5_15_and_PGA_3_Post-Hoc_Analysis_From_Three_Randomized_Controlled_Trials/12554747
10.6084/m9.figshare.12554747.v1